Browsing Tag
Claudin-18.2 antibody-drug conjugate
1 post
Merck strikes €1.4bn deal with Hengrui Pharmaceuticals for next-gen oncology treatments
In a major advancement in cancer treatment, Merck, a frontrunner in science and technology, has declared a strategic…